Are Anti-angiogenics (Bevacizumab) Intravitreal Injections as Effective as Intravitreal Triamcinolone Acetonide Injections for the Management of Persistent Non-infectious Uveitic Cystoid Macular Edema?

被引:0
|
作者
Arevalo, J. Fernando [1 ]
Lasave, Andres F. [2 ]
Ariel Schlaen, Bernardo [3 ]
Zeballos, David [4 ]
Diaz-Llopis, Manuel [5 ]
Avelino Couto, Cristobal [6 ]
El-Haig, Wael [7 ]
机构
[1] Johns Hopkins Univ, Wilmer Eye Inst, Retina Div, Baltimore, MD 21218 USA
[2] Clin Privada Ojos, Retina & Vitreous Serv, Mar Del Plata, Buenos Aires, Argentina
[3] Hosp Univ Austral, Serv Oftalmol, Buenos Aires, DF, Argentina
[4] Clin Ojos, Cuenca, Ecuador
[5] Gen Univ Valencia, Consorcio Hosp, Valencia, Spain
[6] Univ Buenos Aires, Dept Ophthalmol, Uveitis Clin, Buenos Aires, DF, Argentina
[7] Zagazig Univ, Fac Med, Dept Ophthalmol, Zagazig, Egypt
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
420
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion : a Meta - analysis
    Sun, Yan
    Qu, Yi
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2015, 8 (06) : 1234 - 1239
  • [22] Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
    Weber, Lea F.
    Marx, Stefanie
    Auffarth, Gerd U.
    Scheuerle, Alexander F.
    Tandogan, Tamer
    Mayer, Christian
    Khoramnia, Ramin
    JOURNAL OF OPHTHALMIC INFLAMMATION AND INFECTION, 2019, 9 (1)
  • [23] Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema
    Jonas, JB
    Spandau, UH
    Kamppeter, BA
    Vossmerbaeumer, U
    Harder, B
    Sauder, G
    OPHTHALMOLOGY, 2006, 113 (05) : 800 - 804
  • [24] Comparative Therapy Evaluation of Intravitreal Bevacizumab and Triamcinolone Acetonide on Persistent Diffuse Diabetic Macular Edema
    Kumar, Vinod
    Ghosh, Basudeb
    Raina, Usha K.
    Goel, Neha
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 146 (06) : 974 - 974
  • [25] Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema
    Shimura, Masahiko
    Nakazawa, Toru
    Yasuda, Kanako
    Shiono, Takashi
    Iida, Tomohiro
    Sakamoto, Taiji
    Nishida, Koh
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2008, 145 (05) : 854 - 861
  • [26] Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion : a Meta-analysis
    Yan Sun
    Yi Qu
    International Journal of Ophthalmology, 2015, (06) : 1234 - 1239
  • [27] Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
    Chiu, Chiung-Yi
    Huang, Tzu-Lun
    Chang, Pei-Yao
    Chen, Fang-Ting
    Hsu, Yung-Ray
    Chen, Yun-Ju
    Wang, Jia-Kang
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2021, 11 (03) : 251 - 258
  • [28] Diabetic macular edema: Juxtascleral (JS']JS) versus intravitreal (IV) triamcinolone acetonide (TA) injections
    Brancato, R
    Lattanzio, R
    Tremolada, G
    Scotti, F
    Donati, S
    Pierro, L
    Introini, U
    Modorati, G
    Miserocchi, E
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [29] Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis
    Roesel, M.
    Gutfleisch, M.
    Heinz, C.
    Heimes, B.
    Zurek-Imhoff, B.
    Heiligenhaus, A.
    EYE, 2009, 23 (04) : 910 - 914
  • [30] Orbital floor triamcinolone acetonide injections for the management of active non-infectious uveitis
    M Roesel
    M Gutfleisch
    C Heinz
    B Heimes
    B Zurek-Imhoff
    A Heiligenhaus
    Eye, 2009, 23 : 910 - 914